For Immediate Assistance Call 1-800-966-2244

Month: October 2019

News

New Talc Mesothelioma Study May Be Game Changer

Legal experts are indicating that a newly published case study examining talc-based powder’s role in malignant mesothelioma and other asbestos-related diseases may represent a sea change in the future of mesothelioma litigation. The study, which was recently published in the  Journal of Occupational and Environmental Medicine, provides strong support for those who believe that their illnesses were cause by their use of such products as Johnson & Johnson’s Baby Powder, the company’s Shower to Shower product, and Colgate Palmolive’s Cashmere Bouquet body powder.

read more
News

Will Johnson & Johnson Settle More Mesothelioma Lawsuits?

The number of lawsuits accusing Johnson & Johnson’s baby powder and other talc powder products of causing malignant mesothelioma and ovarian cancer has swelled to 15,500, leading many experts to wonder whether the company will begin to settle more of the cases against it. The company has lost many of the cases filed against it, with juries ordering multi-million-dollar compensation amounts paid to victims.

read more
News

Philadelphia Schools Closed Over Mesothelioma Concerns

Exposure to asbestos causes a wide range of serious — and sometimes fatal — diseases, including malignant mesothelioma. Though asbestos companies were long aware of the dangers of this widely-available, inexpensive mineral, they continued subjecting workers and consumers to its risks while they reaped enormous profits from its use. Many of those citizens eventually became victims, suffering and dying from asbestos-related illnesses after having worked with contaminated products for years. Now asbestos is causing those same illnesses in a new group of victims: students and teachers who spend their year in school buildings that used asbestos in their construction.

read more
News

Study Shows Some Mesothelioma Patients Aren’t Getting The Treatment They Deserve

As is true of people diagnosed with any type of cancer, mesothelioma patients need time and information to adjust to the reality of their illness. The word “cancer” always strikes fear, and this is especially true with a condition that carries the weight and limited future that mesothelioma does. Still, once the initial shock has passed most patients want to know what they can do to improve their own odds and outcomes, and to extend the time that they have left to them. Unfortunately, a study conducted at the University of Sydney in Australia has indicated that many physicians are not doing their best to provide their patients with options.

read more
News

Pennsylvania Asbestos Violations Put Countless Workers At Risk of Mesothelioma

Federal charges were filed this past Monday against a real estate developer who stands accused of putting his own employees and others at risk for malignant mesothelioma. The case involves the George Westinghouse Research and Technology Park in Western Pennsylvania, which was purchased by 47-year-old Vikas Jain. Jain bought the one million square foot property with the intention of transforming the former testing and laboratory space into residential and commercial properties, and following that purchase he committed myriad asbestos violations.

read more
News

Mesothelioma Researchers Identify Estrogen As Possible Protective Factor

In the search of a cure for malignant pleural mesothelioma, researchers try to assess both the effect of specific treatment protocols and whether there are certain characteristics that give certain patients an intrinsic advantage and longer survival times. A recent study conducted by researchers at the Mount Sinai Medical Center in New York directed its inquiry in the latter direction, assessing the medical records of over 16,000 mesothelioma patients over the last several years to see whether the ones who lived the longest after diagnosis had any one thing in common. They found that the single characteristics most identified with longer survival was being female. Now they are wondering whether estrogen provides women with added protection against the disease’s effects.

read more